Jove
Visualize
联系我们

相关概念视频

Censoring Survival Data01:09

Censoring Survival Data

72
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
72
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

110
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
110
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

179
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
179
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

196
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
196

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Justifying and reporting the use of severe stress in experiments that use animals.

British journal of pharmacology·2026
Same author

Be CLEAR to ensure methodological and data transparency.

Trends in pharmacological sciences·2025
Same author

Restricted mean survival time based on Wu-Kolassa estimator compared to Kaplan-Meier estimator.

Contemporary clinical trials·2025
Same author

Design of paediatric trials with benefit-risk endpoints using a composite score of adverse events of interest (AEI) and win-statistics.

Journal of biopharmaceutical statistics·2022
Same author

Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.

Pharmaceutical statistics·2022
Same author

Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes.

Pharmaceutical statistics·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

调整后的卡普兰-梅尔估计器的间隔特定审查集.

Yaoshi Wu1, John Kolassa2

  • 1Department of Statistics, UCONN, Storrs, CT, USA.

Journal of applied statistics
|September 13, 2024
PubMed
概括

这项研究引入了一种新的方法,通过减少卡普兰-梅尔 (KM) 估计器中的过高估计来改进生存分析,特别是在高审查率的情况下. 调整后的KM估计器在这些常见场景中提供了更准确的生存估计.

科学领域:

  • 生物统计学 生物统计学
  • 生存分析的分析.
  • 医学统计 医学统计

背景情况:

  • 卡普兰-梅尔 (KM) 估计器是生存分析的标准方法.
  • 在发生审查时,KM估计器可能会高估生存概率.
  • 准确的生存估计对于临床研究和患者的结果至关重要.

研究的目的:

  • 开发一种非参数方法来减少KM估计器中的高估值.
  • 使用特定间隔的审查信息调整KM估计器.
  • 为标准KM估计器提供一致且理论上合理的替代方案.

主要方法:

  • 开发了一个区间特定的审查集调整KM估计器.
  • 为估计器的一致性和偏差减少提供了理论证明.
  • 根据格林伍德的方法推导出一个差异估计公式.
  • 提出了一个修改后的日志等级测试.

主要成果:

  • 与标准KM估计器相比,拟议的估计器显著降低了高估值,特别是在高审查率的情况下.
  • 模拟研究表明,中位生存时间和生存率的偏差显著减少.
  • 建议和KM估计器之间的标准偏差是可比的.
关键词:
审查套件 审查套件卡普兰 - 梅尔估计器独立活动和审查时间.修改后的日志行列测试估计过高的估计.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

相关实验视频

Last Updated: Jun 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
  • 适用于非酒精性脂肪性肝病患者的数据证实了大量的过高估计减少.
  • 结论:

    • 间隔特定的审查设置调整KM估计器提供了更准确的生存概率估计.
    • 这种方法在有大量审查的研究中尤为有益.
    • 这些发现对改善各种医学领域的生存数据分析可靠性有影响.